Dignitana to address Stockholm Corporate Finance Life Science Seminar on March 24
Dignitana Release - wkr0006.pdf
Dignitana AB, global leader in scalp cooling innovation, will participate in the Stockholm Corporate Finance 13th Life Science Capital Markets Days next week. Dignitana CEO William Cronin will present the company’s latest developments and plans beginning at 0800 on 24 March 2021. Click here to register.
Stockholm Corporate Finance, in conjunction with Financial Hearings, has organized the event to give investors, analysts and media the opportunity to meet companies in the Life Science and Health Care industry. The seminar will be a live digital broadcast.
-----
Dignitana announces that as of 15 April 2021 the company will only provide press releases and interim reports in English. The company's annual reports will continue to be published in both Swedish and English.
Dignitana meddelar att bolaget från och med 15 april 2021 endast kommer att tillhandahålla pressmeddelanden och delårsrapporter på engelska. Bolagets årsredovisningar kommer även fortsättningsvis att publiceras på både svenska och engelska.
For More Information Contact
Melissa Bourestom, VP Corporate Communications melissa.bourestom@dignitana.com +1 469-518-5031
About Dignitana
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.se or www.dignicap.com.
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction
Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen
Dignitana hires Johan Johansson to Head Operations, Research and Development
Aktiespararna women’s event to feature Dignitana CEO Catarina Mård Löwenadler
Dignitana newsletter highlights growth and customer satisfaction